ANOBRI Trademark

Trademark Overview

On Thursday, May 18, 2023, a trademark application was filed for ANOBRI with the United States Patent and Trademark Office. The USPTO has given the ANOBRI trademark a serial number of 98002612. The federal status of this trademark filing is REGISTERED as of Tuesday, March 24, 2026. This trademark is owned by ANOVENT PHARMACEUTICAL (U.S.), LLC. The ANOBRI trademark is filed in the Pharmaceutical Products category with the following description:

Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with pharmaceutical preparations for treating respiratory diseases and disorders; Medicated throat sprays; Pharmaceutical products for treating respiratory diseases and asthma
anobri

General Information

Serial Number98002612
Word MarkANOBRI
Filing DateThursday, May 18, 2023
Status700 - REGISTERED
Status DateTuesday, March 24, 2026
Registration Number8188203
Registration DateTuesday, March 24, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements

Goods and ServicesInhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with pharmaceutical preparations for treating respiratory diseases and disorders; Medicated throat sprays; Pharmaceutical products for treating respiratory diseases and asthma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 20, 2023
Primary Code005
First Use Anywhere DateThursday, June 19, 2025
First Use In Commerce DateThursday, June 19, 2025

Trademark Owner History

Party NameANOBRI PHARMACEUTICALS US, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNEWARK, NJ 07102
US
Party NameANOBRI PHARMACEUTICALS US, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNEWARK, NJ 07102
US
Party NameANOBRI PHARMACEUTICALS US, LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressNEWARK, NJ 07102
US
Party NameANOVENT PHARMACEUTICAL (U.S.), LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNewark, NJ 07102
US

Trademark Events

Event DateEvent Description
Monday, May 22, 2023NEW APPLICATION ENTERED
Wednesday, June 14, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 12, 2024ASSIGNED TO EXAMINER
Friday, February 16, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, February 16, 2024EXAMINERS AMENDMENT E-MAILED
Friday, February 16, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 16, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, February 28, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 15, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 22, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 15, 2024SOU EXTENSION 1 FILED
Monday, January 27, 2025SOU EXTENSION 1 GRANTED
Monday, January 27, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 29, 2025SOU TEAS EXTENSION RECEIVED
Thursday, May 29, 2025SOU EXTENSION 2 FILED
Thursday, May 29, 2025SOU EXTENSION 2 GRANTED
Monday, July 7, 2025TEAS STATEMENT OF USE RECEIVED
Monday, July 7, 2025USE AMENDMENT FILED
Tuesday, July 8, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, July 11, 2025SU - NON-FINAL ACTION - WRITTEN
Friday, July 11, 2025NON-FINAL ACTION E-MAILED
Friday, July 11, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 10, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, October 10, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, January 9, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 15, 2026ASSIGNED TO LIE
Thursday, January 15, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 15, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 16, 2026SU - FINAL REFUSAL - WRITTEN
Friday, January 16, 2026FINAL REFUSAL E-MAILED
Friday, January 16, 2026NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, March 3, 2026TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, March 3, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 3, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 3, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 3, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 24, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, March 24, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

anobri diseases respiratory pharmaceutical treating preparations disorders throat sprays products asthma